rs141233891

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001849.4(COL6A2):​c.2683A>C​(p.Ser895Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00177 in 1,572,704 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S895N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0018 ( 4 hom. )

Consequence

COL6A2
NM_001849.4 missense

Scores

1
5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.09

Publications

8 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008235663).
BP6
Variant 21-46132175-A-C is Benign according to our data. Variant chr21-46132175-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 196119.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.2683A>C p.Ser895Arg missense_variant Exon 28 of 28 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.2683A>C p.Ser895Arg missense_variant Exon 28 of 28 1 NM_001849.4 ENSP00000300527.4 P12110-1

Frequencies

GnomAD3 genomes
AF:
0.00123
AC:
187
AN:
152164
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00234
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00128
AC:
231
AN:
180392
AF XY:
0.00142
show subpopulations
Gnomad AFR exome
AF:
0.000295
Gnomad AMR exome
AF:
0.000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000644
Gnomad NFE exome
AF:
0.00192
Gnomad OTH exome
AF:
0.000206
GnomAD4 exome
AF:
0.00183
AC:
2595
AN:
1420422
Hom.:
4
Cov.:
33
AF XY:
0.00182
AC XY:
1281
AN XY:
703550
show subpopulations
African (AFR)
AF:
0.000155
AC:
5
AN:
32334
American (AMR)
AF:
0.000364
AC:
14
AN:
38506
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25428
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36840
South Asian (SAS)
AF:
0.00196
AC:
161
AN:
81968
European-Finnish (FIN)
AF:
0.000124
AC:
6
AN:
48388
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5726
European-Non Finnish (NFE)
AF:
0.00211
AC:
2310
AN:
1092350
Other (OTH)
AF:
0.00155
AC:
91
AN:
58882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
191
381
572
762
953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00123
AC:
188
AN:
152282
Hom.:
1
Cov.:
34
AF XY:
0.00110
AC XY:
82
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41560
American (AMR)
AF:
0.000196
AC:
3
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4828
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00234
AC:
159
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00161
Hom.:
0
Bravo
AF:
0.00108
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000689
AC:
3
ESP6500EA
AF:
0.00164
AC:
14
ExAC
AF:
0.00106
AC:
127
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 30, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24036952, 17886299) -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL6A2: BP4, BS1 -

not specified Benign:1
Nov 06, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Bethlem myopathy 1A Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COL6A2-related disorder Benign:1
Oct 12, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.25
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.072
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.0082
T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
0.90
L
PhyloP100
4.1
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.79
N
REVEL
Benign
0.29
Sift
Benign
0.54
T
Sift4G
Benign
0.52
T
Polyphen
0.21
B
Vest4
0.29
MutPred
0.20
Gain of solvent accessibility (P = 0.204);
MVP
0.88
MPC
0.20
ClinPred
0.023
T
GERP RS
4.2
Varity_R
0.14
gMVP
0.74
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141233891; hg19: chr21-47552089; API